UBS AM
PHVS icon

UBS AM’s Pharvaris PHVS Stock Holding History

UBS AM’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-77,646
Closed -$2.19M – 3828
2026
Q1 		$2.19M Sell
77,646
-6,301
-8% -$168K ﹤0.01% 2005
2025
Q4 		$2.33M Buy
+83,947
New +$2.02M ﹤0.01% 1827
2025
Q3 		– Sell
-55,377
Closed -$975K – 2516
2025
Q2 		$975K Sell
55,377
-12,954
-19% -$209K ﹤0.01% 2392
2025
Q1 		$1.07M Buy
68,331
+4,597
+7% +$77.5K ﹤0.01% 2274
2024
Q4 		$1.22M Buy
63,734
+14,838
+30% +$305K ﹤0.01% 2290
2024
Q3 		$906K Buy
+48,896
New +$893K ﹤0.01% 2446

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

UBS AM's PHVS Position: Q2 2026 in Review

UBS AM sold out of Pharvaris (PHVS) in Q2 2026, closing a stake of 77,646 shares — an estimated $2.19M sold.

UBS AM first reported a position in PHVS in Q3 2024 and held it in 6 quarters. The position peaked at $2.33M in Q4 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • UBS AM reported no remaining Pharvaris position as of Q2 2026 after selling out during the quarter.
  • UBS AM sold 77,646 Pharvaris shares in Q2 2026, an estimated $2.19M.
  • UBS AM first reported a position in Pharvaris in Q3 2024 and held it in 6 quarters.
  • UBS AM's Pharvaris position peaked at $2.33M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.